Abstract
To investigate the genetic characteristics of human influenza viruses circulating in Chungbuk province, we tested 510 clinical samples of nasopharyngeal suction from pediatric patients diagnosed with respiratory illness between June 2007 and June 2008. Genetic characterization of the HA genes of H3N2 isolates indicated the relative higher similarity to A/Virginia/04/07 (99.6%) rather than that of A/Wisconsin/67/2005 (98.4%), a Northern Hemisphere 2007∼2008 vaccine strain, based on amino acid sequences. We found several altered amino acids at the H3 HA1 antigenic sites compared with the vaccine strain; K140I at site A, K158R at site B, and K173N (H471) or K173Q, and S262N at site E, but there was no antigenic shift among the H3N2 viruses. Interestingly, A/Cheongju/H383/08 and A/Cheongju/H407/08 isolates had single amino acid substitution at D151G on the catalytic site of the N2 NA while A/Cheongju/H412/08 and A/Cheongju/ H398/07 isolates had one amino acid deletion at residue 146. Furthermore, we found that 25% (3 out of 12 isolates) of the H3N2 subtype viruses had the amino acid substitution at position 31 on the M2 protein (Aspartic acid to Asparagine) and confirmed their drug-resistance by biological assays. Taken together, the results of this study demonstrated continuous evolutions of human H3N2 viruses by antigenic drift and also highlighted the need to closely monitor antigenic drug resistance in influenza A viruses to aid in the early detection of potentially pandemic strains, as well as underscore the need for new therapeutics.
Article PDF
Similar content being viewed by others
References
Air, G.M. and W.G. Laver. 1986. The molecular basis of antigenic variation in influenza virus. Adv. Virus Res. 31, 53–102.
Barr, I.G., N. Komadina, A. Hurt, R. Shaw, C. Durrant, P. Iannello, C. Tomasov, H. Sjogren, and A.W. Hampson. 2003. Reassortants in recent human influenza A and B isolates from South East Asia and Oceania. Virus Res. 98, 35–44.
Castrucci, M.R., I. Donatelli, L. Sidoli, G. Barigazzi, Y. Kawaoka, and R.G. Webster. 1993. Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology 193, 503–506.
Chang, H.K., J.H. Park, M.S. Song, T.K. Oh, S.Y. Kim, C.J. Kim, H. Kim, M.H. Sung, H.S. Han, Y.S. Hahn, and Y.K. Choi. 2008. Development of multiplex RT-PCR assays for rapid detection and subtyping of influenza type a viruses from clinical specimens. J. Microbiol. Biotechnol. 18, 1164–1169.
Daniels, R.S., A.R. Douglas, J.J. Skehel, D.C. Wiley, C.W. Naeve, R.G. Webster, G.N. Rogers, and J.C. Paulson. 1984. Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. Virology 138, 174–177.
Ellis, J.S., A. Varez-Aguero, V. Gregory, Y.P. Lin, A. Hay, and M.C. Zambon. 2003. Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season. Emerg. Infect. Dis. 9, 304–310.
Fitch, W.M., R.M. Bush, C.A. Bender, and N.J. Cox. 1997. Long term trends in the evolution of H(3) HA1 human influenza type A. Proc. Natl. Acad. Sci. USA 94, 7712–7718.
Ghate, A.A. and G.M. Air. 1998. Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design. Eur. J. Biochem. 258, 320–331.
Guo, Y.J., F.G. Jin, P. Wang, M. Wang, and J.M. Zhu. 1983. Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus. J. Gen. Virol. 64, 177–182.
Kawaoka, Y., S. Krauss, and R.G. Webster. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63, 4603–4608.
Laver, W.G., G.M. Air, and R.G. Webster. 1981. Mechanism of antigenic drift in influenza virus. Amino acid sequence changes in an antigenically active region of Hong Kong (H3N2) influenza virus hemagglutinin. J. Mol. Biol. 145, 339–361.
Lin, Y.P., V. Gregory, M. Bennett, and A. Hay. 2004. Recent changes among human influenza viruses. Virus Res. 103, 47–52.
Lindstrom, S., S. Sugita, A. Endo, M. Ishida, P. Huang, S.H. Xi, and K. Nerome. 1996. Evolutionary characterization of recent human H3N2 influenza A isolates from Japan and China: novel changes in the receptor binding domain. Arch. Virol. 141, 1349–1355.
Masuda, H., H. Suzuki, H. Oshitani, R. Saito, S. Kawasaki, M. Nishikawa, and H. Satoh. 2000. Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan. Microbiol. Immunol. 44, 833–839.
Matrosovich, M., A. Tuzikov, N. Bovin, A. Gambaryan, A. Klimov, M.R. Castrucci, I. Donatelli, and Y. Kawaoka. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74, 8502–8512.
Mitnaul, L.J., M.N. Matrosovich, M.R. Castrucci, A.B. Tuzikov, N.V. Bovin, D. Kobasa, and Y. Kawaoka. 2000. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74, 6015–6020.
Osterhaus, A.D., G.F. Rimmelzwaan, B.E. Martina, T.M. Bestebroer, and R.A. Fouchier. 2000. Influenza B virus in seals. Science 288, 1051–1053.
Palmer, D.F., W.R. Dowdle, M.T. Coleman, and G.C. Schild. 1975. Advanced laboratory techniques for influenza diagnosis, U.S. Dept. Health Educ. Welf. Immun. Ser 6. 1975. Atlanta, GA, Center for Disease Control.
Parrish, C.R. and Y. Kawaoka. 2005. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu. Rev. Microbiol. 59, 553–586.
Reed, L.J. and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493–497.
Skehel, J.J. and D.C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531–569.
Varghese, J.N. and P.M. Colman. 1991. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. J. Mol. Biol. 221, 473–486.
Vines, A., K. Wells, M. Matrosovich, M.R. Castrucci, T. Ito, and Y. Kawaoka. 1998. The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J. Virol. 72, 7626–7631.
Webster, R.G. 1997. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch. Virol. Suppl. 13, 105–113.
Webster, R.G., W.G. Laver, and B. Tumova. 1975. Studies on the origin of pandemic influenza viruses V. Persistence of Asian influenza virus hemagglutinin (H2) antigen in nature? Virology 67, 534–543.
Wiley, D.C, LA. Wilson, and J.J. Skehel. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373–378.
Wright, P.F. and R.G. Webster. 2001. Orthomyxoviruses. In B.N. Hawley (ed.), Fields KDM, Lippencott-Raven, Pa, USA.
Xu, X., S.E. Lindstrom, M.W. Shaw, C.B. Smith, H.E. Hall, B.A. Mungall, K. Subbarao, N.J. Cox, and A. Klimov. 2004. Reassortment and evolution of current human influenza A and B viruses. Virus Res. 103, 55–60.
Xu, X., C.B. Smith, B.A. Mungall, S.E. Lindstrom, H.E. Hall, K. Subbarao, N.J. Cox, and A. Klimov. 2002. Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001–2002 influenza season. J. Infect. Dis. 186, 1490–1493.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baek, Y.H., Park, J.H., Song, Y.J. et al. Molecular characterization and phylogenetic analysis of H3N2 human influenza A viruses in Cheongju, South Korea. J Microbiol. 47, 91–100 (2009). https://doi.org/10.1007/s12275-008-0207-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-008-0207-y